Emergent Biosolutions Inc. buy Rodman & Renshaw
Start price
22.08.24
/
50%
€9.52
Target price
22.08.25
€14.36
Performance (%)
-19.54%
Price
01.10.24
€7.66
Summary
This prediction is currently active. The prediction for Emergent Biosolutions Inc. disappoints with a performance of -19.54%. This prediction currently runs until 22.08.25. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Emergent Biosolutions Inc. | 37.083% | 37.083% |
iShares Core DAX® | 2.685% | 2.476% |
iShares Nasdaq 100 | 0.803% | 1.741% |
iShares Nikkei 225® | -0.583% | -1.037% |
iShares S&P 500 | 0.638% | 1.486% |
Comments by Rodman___Renshaw for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $16.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
Stopped prediction by Rodman___Renshaw for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€7.16
13.09.24
13.09.24
€14.43
13.09.25
13.09.25
6.96%
01.10.24
01.10.24